202 related articles for article (PubMed ID: 33054844)
1. Patient-reported outcomes on familial amyloid polyneuropathy (FAP).
Bolte FJ; Langenstroer C; Friebel F; Hüsing-Kabar A; Dugas M; Schmidt HH
Orphanet J Rare Dis; 2020 Oct; 15(1):287. PubMed ID: 33054844
[TBL] [Abstract][Full Text] [Related]
2. Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups.
Rintell D; Heath D; Braga Mendendez F; Cross E; Cross T; Knobel V; Gagnon B; Turtle C; Cohen A; Kalmykov E; Fox J
Orphanet J Rare Dis; 2021 Feb; 16(1):70. PubMed ID: 33557882
[TBL] [Abstract][Full Text] [Related]
3. [Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder].
Niemietz C; Röcken C; Schilling M; Stypmann J; Uhlig CE; Schmidt HH
Dtsch Med Wochenschr; 2018 Mar; 143(6):427-430. PubMed ID: 29544239
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.
Sekijima Y; Ueda M; Koike H; Misawa S; Ishii T; Ando Y
Orphanet J Rare Dis; 2018 Jan; 13(1):6. PubMed ID: 29343286
[TBL] [Abstract][Full Text] [Related]
5. Baseline disease characteristics in Brazilian patients enrolled in Transthyretin Amyloidosis Outcome Survey (THAOS).
Cruz MW; Pinto MV; Pinto LF; Gervais R; Dias M; Perez C; Mundayat R; Ong ML; Pedrosa RC; Foguel D
Arq Neuropsiquiatr; 2019 Feb; 77(2):96-100. PubMed ID: 30810593
[TBL] [Abstract][Full Text] [Related]
6. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
Sekijima Y
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
[TBL] [Abstract][Full Text] [Related]
7. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation.
Lipowska M; Drac H; Rowczenio D; Gilbertson J; Hawkins PN; Lasek-Bal A; Szewczuk J; Grzybowski J; Gawor M; Stępień-Wojno M; Franaszczyk M; Brydak-Godowska J; Śmierciak R; Ptasińska-Perkowska A; Chandoga J; Petrovic R; Kostera-Pruszczyk A
Neurol Neurochir Pol; 2020; 54(6):552-560. PubMed ID: 33373035
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy.
Hattori T; Takei Y; Koyama J; Nakazato M; Ikeda S
Amyloid; 2003 Dec; 10(4):229-39. PubMed ID: 14986482
[TBL] [Abstract][Full Text] [Related]
9. Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy.
Tojo K; Tsuchiya-Suzuki A; Sekijima Y; Morita H; Sumita N; Ikeda S
Amyloid; 2010 Mar; 17(1):32-5. PubMed ID: 20132088
[TBL] [Abstract][Full Text] [Related]
10. Serum Proteomic Variability Associated with Clinical Phenotype in Familial Transthyretin Amyloidosis (ATTRm).
Chan GG; Koch CM; Connors LH
J Proteome Res; 2017 Nov; 16(11):4104-4112. PubMed ID: 28922609
[TBL] [Abstract][Full Text] [Related]
11. [Two elderly cases of transthyretin amyloid polyneuropathy without a family history].
Nomura T; Oshima Y; Yoshino M; Matsushima M; Yabe I; Sasaki H
Rinsho Shinkeigaku; 2020 Oct; 60(10):688-692. PubMed ID: 32893242
[TBL] [Abstract][Full Text] [Related]
12. SELDI-TOF mass spectrometry evaluation of variant transthyretins for diagnosis and pathogenesis of familial amyloidotic polyneuropathy.
Ueda M; Misumi Y; Mizuguchi M; Nakamura M; Yamashita T; Sekijima Y; Ota K; Shinriki S; Jono H; Ikeda S; Suhr OB; Ando Y
Clin Chem; 2009 Jun; 55(6):1223-7. PubMed ID: 19372189
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Oligonucleotide-Based Therapy for Transthyretin Amyloidosis: Clinical Impact and Future Prospects.
Hayashi Y; Jono H
Biol Pharm Bull; 2018; 41(12):1737-1744. PubMed ID: 30504675
[TBL] [Abstract][Full Text] [Related]
14. Impact of antibodies against amyloidogenic transthyretin (ATTR) on phenotypes of patients with familial amyloidotic polyneuropathy (FAP) ATTR Valine30Methionine.
Obayashi K; Tasaki M; Jono H; Ueda M; Shinriki S; Misumi Y; Yamashita T; Oshima T; Nakamura T; Ikemizu S; Anan I; Suhr O; Ando Y
Clin Chim Acta; 2013 Apr; 419():127-31. PubMed ID: 23462670
[TBL] [Abstract][Full Text] [Related]
15. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan.
Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A
Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis.
Koike H; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Tanaka F; Sobue G
Amyloid; 2011 Jun; 18(2):53-62. PubMed ID: 21463231
[TBL] [Abstract][Full Text] [Related]
17. Evidence of the presence of amyloid substance in the blood of familial amyloidotic polyneuropathy patients with ATTR Val30Met mutation.
Liu J; Lan J; Zhao P; Zheng F; Song J; Zhang P; Sun X
Int J Clin Exp Pathol; 2014; 7(11):7795-800. PubMed ID: 25550818
[TBL] [Abstract][Full Text] [Related]
18. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
[TBL] [Abstract][Full Text] [Related]
19. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
[TBL] [Abstract][Full Text] [Related]
20. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).
Maurer MS; Hanna M; Grogan M; Dispenzieri A; Witteles R; Drachman B; Judge DP; Lenihan DJ; Gottlieb SS; Shah SJ; Steidley DE; Ventura H; Murali S; Silver MA; Jacoby D; Fedson S; Hummel SL; Kristen AV; Damy T; Planté-Bordeneuve V; Coelho T; Mundayat R; Suhr OB; Waddington Cruz M; Rapezzi C;
J Am Coll Cardiol; 2016 Jul; 68(2):161-72. PubMed ID: 27386769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
